Company research / SNDX
Syndax Pharmaceuticals Inc (SNDX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Syndax Pharmaceuticals Inc reported revenue of $172.35M. Revenue grew 627.8% from the prior annual period.
Key ratios (year ended 2025-12-31)
-158.4%
Operating margin
-165.6%
Net margin
-441.6%
Return on year-end equity
627.8%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.